QP 08 - CNS Metastases and LMD: Patient Selection, Treatment Strategy and Outcomes

Presentations

• 03:00pm - 03:05pm ET

  Introductions

  Speaker: William Breen, MD - Mayo Clinic Rochester, Rochester
• 03:05pm - 03:10pm ET

  Inferring the Initiation Site of Brain Necrosis from Proton Therapy via Inverse Mechanistic Modeling

  Speaker: Nicolo Cogno, PhD - Massachusetts General Hospital and Harvard Medical School, Boston
• 03:10pm - 03:15pm ET

  The Influence of Cancer Primary Site on Outcomes after Preoperative Radiosurgery for Resected Brain Metastases: A XXX International Multicenter Cohort Study

  Speaker: Roshan Prabhu, MD, MS - Atrium Health Levine Cancer, CHARLOTTE
• 03:15pm - 03:20pm ET

  Proton vs. Photon Craniospinal Irradiation for Leptomeningeal Disease: Comparative Clinical Outcomes and Acute Toxicities

  Speaker: Audi Hoang, BS - Tilman J Fertitta Family College of Medicine, Houston
• 03:20pm - 03:25pm ET

  Pembrolizumab and Stereotactic Radiosurgery (SRS) of Selected Brain Metastases in Breast Cancer Patients

  Speaker: Fabiana Gregucci, - Weill Cornell Medical College, New York
• 03:25pm - 03:30pm ET

  Hematologic Toxicity, Treatment Completion Time, and Dosimetric Comparison between Proton and Photon Craniospinal Irradiation in Pediatric Tumor Patients: A Propensity Score-Matched Study

  Speaker: Ran Li, PhD - Shandong Cancer Hospital, Shandong Provincial Key Medical and Health Laboratory of Pediatric Cancer Precision Radiotherapy, Ji Nan
• 03:30pm - 03:35pm ET

  Predicting Survival and Treatment Completion of Proton Craniospinal Irradiation in Leptomeningeal Disease: A Prognostic Nomogram

  Speaker: Tejaswi Kanala, MD, MBBS - MD Anderson Cancer Center, Houston
• 03:35pm - 03:55pm ET

  Questions & Answers

  Speaker: Jonathan Yang, MD, PhD - New York University School of Medicine, New York
• 03:55pm - 04:00pm ET

  Closing

  Speaker: William Breen, MD - Mayo Clinic Rochester, Rochester